JNJCAUTIOUS

JNJ P/E Ratio Analysis

30.2x

Higher than 0% of HEALTHCARE sector peers

Updated 57h ago·SEC filings & market data

Key Takeaway

The P/E ratio of 30.2x means investors currently pay $30.20 for every $1.00 of JNJ's annual earnings per share.

Sector Performance

0th percentile

JNJ

30.2x

Sector Median

30.9x

Sector Avg

30.9x

Prior Period

29.1x(Jul 2026)

↓ Declining

📊

Deep Analysis

The P/E ratio of 30.2x means investors currently pay $30.20 for every $1.00 of JNJ's annual earnings per share.

That is slightly below the healthcare sector median of 30.9x, placing JNJ at the 0th percentile among sector peers, meaning it is the cheapest or among the cheapest on this measure. The year-over-year change is not available, but the quarter-over-quarter change shows a +3.7% rise from 29.1x to 30.2x. A valuation that is still slightly cheaper than peers but moving upward suggests the market's willingness to pay for earnings is increasing, which can lift near-term price but adds downside risk if earnings disappoint. This metric supports the overall CAUTIOUS

Frequently Asked Questions

What does the P/E Ratio tell investors about JNJ?

Measures how much investors pay per dollar of earnings. A high P/E signals growth expectations; a low P/E may indicate undervaluation or slow growth.

How is the P/E Ratio calculated?

P/E Ratio is calculated as: Price / EPS.

How does JNJ's P/E Ratio compare to its sector?

JNJ's P/E Ratio of 30.2x compares to a HEALTHCARE sector median of 30.9x, placing it in the 0th percentile.

Who are JNJ's closest peers by P/E Ratio?

The closest HEALTHCARE peers by P/E Ratio include: UNH (31.7x).

📚

Learn More About P/E Ratio

DCF Valuation: How to Estimate What a Stock Is Actually Worth

Discounted Cash Flow is the most rigorous way to value a company. It's also the most misunderstood. Here's a plain-English walkthrough with a real example.

The Formula

Price / EPS

Why It Matters

Measures how much investors pay per dollar of earnings. A high P/E signals growth expectations; a low P/E may indicate undervaluation or slow growth.